Foundation Medicine and AstraZeneca Announce Genomic Profiling Collaboration

News   Nov 12, 2012

 
Foundation Medicine and AstraZeneca Announce Genomic Profiling Collaboration
 
 
 
 

RELATED ARTICLES

Could This Be a "Silver Bullet" for Preventing and Treating Colon Cancer?

News

A team of scientists targeted the gene CtBP with a drug known as HIPP (2-hydroxy-imino phenylpyruvic acid) and were able to reduce the development of pre-cancerous polyps by half.

READ MORE

FDA Grants Full Approval to Blinatumomab for Acute Lymphoblastic Leukemia

News

TheFDA has changed its accelerated approval of blinatumomab (Blincyto®) for some patients with acute lymphoblastic leukemia to a full approval and expanded the approved indications for its use.

READ MORE

GWAS Reveals Genes Associated with Lean Body Mass

News

Findings could lead to future therapies to preserve muscle mass as we age.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE